Inactive Instrument

News AtheroNova Inc. OTC Bulletin Board

Equities

AHRO

US0474382050

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

2016	AtheroNova Operations, Inc. Bankruptcy Case Dismissed	CI
2015	First Motion for Exclusivity Period Extension Approved For AtheroNova Operations, Inc.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AtheroNova Operations, Inc. Bankruptcy Case Dismissed	16-05-18	CI
First Motion for Exclusivity Period Extension Approved For AtheroNova Operations, Inc.	15-08-14	CI
First Motion for Exclusivity Period Extension Filed by AtheroNova Operations, Inc.	15-06-24	CI
Reorganization Plan and Disclosure Statement Filed by AtheroNova Operations, Inc.	15-06-22	CI
AtheroNova Inc. will Change its Ticker to AHRO.Q from AHRO	15-03-04	CI
AtheroNova : and its Subsidiary File for Chapter 11 Bankruptcy Protection	15-03-03	PR
AtheroNova To Sell Assets Under Chapter 11	15-03-03	CI
Motion for Joint Administration Approved for AtheroNova Operations, Inc.	15-03-02	CI
AtheroNova Operations, Inc. Filed for Bankruptcy	15-03-01	CI
Motion for Joint Administration Filed by AtheroNova Operations, Inc.	15-03-01	CI
AtheroNova : Receives Notice of Issuance of Its 3rd US Patent	15-02-13	PR
Certain shares of AtheroNova Inc.'s Common Stock are subject to a Lock-Up Agreement Ending on 26-JAN-2015.	15-01-26	CI
Certain shares of AtheroNova Inc.'s Common Stock are subject to a Lock-Up Agreement Ending on 26-JAN-2015.	15-01-25	CI
AtheroNova Inc. Announces Resignation of Chaim Davis from the Board of Directors	14-12-09	CI
AtheroNova Inc. Announces Resignation of Gary Freeman as a Member of Board of Directors and Chair of Audit Committee	14-11-20	CI
AtheroNova : Announces Closing of Public Offering of Common Stock and Warrants	14-10-31	PR
AtheroNova : Prices Public Offering of Common Stock and Warrants	14-10-28	PR
AtheroNova Inc. announced that it has received $0.5 million in funding from W-Net Fund I, L.P.	14-09-11	CI
AtheroNova : Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001	14-07-30	PR
Atheronova Inc. Accomplishes First Dosing of Subjects for its Phase 1B Clinical Trial with AHRO-001	14-07-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News AtheroNova Inc. OTC Bulletin Board

Equities

AHRO

US0474382050

Summary

Filters